作为一个有前途的抗微生物策略的曼诺-寡糖:病原体抑制和与抗生素的协同效应
Rachel E Asbury1,2, Bradley A Saville1
1Bioprocess and Enzyme Technology Lab, Department of Chemical Engineering and Applied Chemistry, University of Toronto, Toronto, ON, Canada.
Frontiers in microbiology
|April 8, 2025
概括
曼诺寡糖 (MOS) 通过抑制细菌生长和提高抗生素有效性,显示出作为抗生素替代品的潜力. 它们的结构影响抗菌性质,提供了对抗感染的有希望的策略.
科学领域:
- 微生物学 微生物学
- 生物化学 生化学
- 药理学 药理学是指药理学的学科.
背景情况:
- 抗微生物药物耐药性的增加需要超越传统抗生素的新疗法策略.
- 致病性细菌感染对人类和动物来说是一个重大的全球健康挑战.
- 曼诺寡糖 (MOS) 显示出病原体结合能力,防止细菌粘附到宿主上皮细胞.
研究的目的:
- 研究各种β-曼诺-寡糖 (β-MOS) 产品在抑制关键细菌病原体生长方面的疗效.
- 评估β-MOS在增强现有抗生素有效性的协同作用.
- 阐明碳水化合物结构在MOS的抗菌活性中的作用.
主要方法:
- 在体外测试β-MOS产品对大肠杆菌,肺炎菌,单细胞菌菌和突变性菌杆菌进行检测.
- 在存在β-MOS.时,评估细菌生长抑制区和最小抑制度 (MICs).
- 通过使用标准抗微生物敏感性测试方法评估β-MOS的抗生素强化.
主要成果:
- 观察到每个细菌菌株的明显抑制特征,与β-MOS结构有所不同.
- 某些β-MOS配方显著抑制了测试的致病细菌的生长.
- 观察到协同效应,MOS增强了抗生素的有效性,以塞夫塔齐迪姆 (ceftazidime) 作为对*K. pneumoniae*的例子.
结论:
- 像MOS这样的不可消化的寡糖的结构特征是它们抗菌性能的关键决定因素.
- MOS代表了一种有前途的替代和辅助治疗策略,用于管理细菌感染,特别是在抗菌素耐药性的背景下.
- 对特定β-MOS结构的进一步研究可以优化它们在打击细菌病原体中的应用.
更多相关视频
相关概念视频
Combined Effects of Drugs: Synergism
3.6K
Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...
Such synergistic combinations...
3.6K
Antimicrobial Proteins
751
Antimicrobial proteins are important components of the immune system. They aid the body in combating pathogens by either killing them directly or hindering their replication processes. Four main types of antimicrobial substances are interferons, the complement system, iron-binding proteins, and antimicrobial proteins.
Interferons
Interferons (IFNs) are proteins produced by lymphocytes, macrophages, and fibroblasts infected with viruses. While IFNs cannot prevent viruses from entering and...
Interferons
Interferons (IFNs) are proteins produced by lymphocytes, macrophages, and fibroblasts infected with viruses. While IFNs cannot prevent viruses from entering and...
751
Surface Membrane Barriers
693
The skin and mucous membranes serve as the primary line of defense against pathogens by providing both physical and chemical protection. These barriers are essential in preventing the entry and establishment of microbes, thereby maintaining the integrity of the host.
The outer layer of the skin, the epidermis, is a robust barrier comprising layers of closely packed keratinized cells. This dense arrangement prevents microbes from penetrating the body. The periodic shedding of epidermal cells...
The outer layer of the skin, the epidermis, is a robust barrier comprising layers of closely packed keratinized cells. This dense arrangement prevents microbes from penetrating the body. The periodic shedding of epidermal cells...
693
Defense Against Bacterial Pathogens
1.3K
The human immune system is a complex network of cells, tissues, and organs that work together to defend the body against bacterial infections. It consists of various immune cells, each playing a specific role in the defense mechanism.
Phagocytes
Phagocytes are the frontline soldiers of the immune system. They include neutrophils and macrophages. Neutrophils are the most abundant type of white blood cell and are quickly mobilized to the site of infection. Macrophages are larger cells that patrol...
Phagocytes
Phagocytes are the frontline soldiers of the immune system. They include neutrophils and macrophages. Neutrophils are the most abundant type of white blood cell and are quickly mobilized to the site of infection. Macrophages are larger cells that patrol...
1.3K


